These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 33670347

  • 1. Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization.
    Du Y, Paglicawan L, Soomro S, Abunofal O, Baig S, Vanarsa K, Hicks J, Mohan C.
    Nutrients; 2021 Feb 11; 13(2):. PubMed ID: 33670347
    [Abstract] [Full Text] [Related]

  • 2. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y, Sun X, Chen Y, Deng Y, Qian K.
    Eur J Pharmacol; 2015 Aug 15; 761():405-12. PubMed ID: 25967348
    [Abstract] [Full Text] [Related]

  • 3. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
    Gan L, Meng ZJ, Xiong RB, Guo JQ, Lu XC, Zheng ZW, Deng YP, Luo BD, Zou F, Li H.
    Acta Pharmacol Sin; 2015 May 15; 36(5):597-605. PubMed ID: 25891086
    [Abstract] [Full Text] [Related]

  • 4. Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4.
    Yang M, Yan R, Sha R, Wang X, Zhou S, Li B, Zheng Q, Cao Y.
    Clin Nutr; 2024 Aug 15; 43(8):1769-1780. PubMed ID: 38936303
    [Abstract] [Full Text] [Related]

  • 5. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
    Santamarina AB, Carvalho-Silva M, Gomes LM, Okuda MH, Santana AA, Streck EL, Seelaender M, do Nascimento CM, Ribeiro EB, Lira FS, Oyama LM.
    J Nutr Biochem; 2015 Nov 15; 26(11):1348-56. PubMed ID: 26300331
    [Abstract] [Full Text] [Related]

  • 6. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.
    Coia H, Ma N, Hou Y, Permaul E, Berry DL, Cruz MI, Pannkuk E, Girgis M, Zhu Z, Lee Y, Rodriquez O, Cheema A, Chung FL.
    Clin Nutr; 2021 Jan 15; 40(1):110-119. PubMed ID: 32439267
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation.
    Mao D, Guo J, Yang K, Yang F, Peng J, Jia X, Luo Z, Liu L, Yang E, Tang R, Lan H, Zheng Q.
    Biochem Biophys Res Commun; 2024 Nov 19; 734():150424. PubMed ID: 39083974
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

  • 14. Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway.
    Wu D, Liu Z, Wang Y, Zhang Q, Li J, Zhong P, Xie Z, Ji A, Li Y.
    Oxid Med Cell Longev; 2021 Mar 18; 2021():5599997. PubMed ID: 33953830
    [Abstract] [Full Text] [Related]

  • 15. An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice.
    Jurado-Ruiz E, Varela LM, Luque A, Berná G, Cahuana G, Martinez-Force E, Gallego-Durán R, Soria B, de Roos B, Romero Gómez M, Martín F.
    Mol Nutr Food Res; 2017 Mar 18; 61(3):. PubMed ID: 27749006
    [Abstract] [Full Text] [Related]

  • 16. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
    Kuzu N, Bahcecioglu IH, Dagli AF, Ozercan IH, Ustündag B, Sahin K.
    J Gastroenterol Hepatol; 2008 Aug 18; 23(8 Pt 2):e465-70. PubMed ID: 17683497
    [Abstract] [Full Text] [Related]

  • 17. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G.
    J Transl Med; 2015 Jun 16; 13():193. PubMed ID: 26077675
    [Abstract] [Full Text] [Related]

  • 18. [Study on the state of macrophage infiltration in the progression of non-alcoholic fatty liver disease induced by high-fat diet in mice].
    Zhong L, Xu KS, Deng L.
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec 20; 28(12):1042-1047. PubMed ID: 34865353
    [Abstract] [Full Text] [Related]

  • 19. Hepatoprotective effects and mechanisms of l-theanine and epigallocatechin gallate combined intervention in alcoholic fatty liver rats.
    Xu KH, Yang DF, Liu MY, Xu W, Li YH, Xiao WJ.
    J Sci Food Agric; 2024 Oct 20; 104(13):8230-8239. PubMed ID: 38873964
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy.
    Yu T, Wang L, Cheng Y, Zhang Y, Zhu J, Zhang G, Hu S.
    Biochem Biophys Res Commun; 2024 Sep 24; 726():150264. PubMed ID: 38905784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.